Download Dr. med. Sylke Schneider-Burrus

PROFIL
Dr. med. Sylke Schneider-Burrus
Chefärztin Zentrum für Dermatochirurgie
Dr. med. Sylke Schneider-Burrus wurde am 04.05.1973 in Hückeswagen,
Nordrhein-Westfalen geboren. Sie ist verheiratet und hat zwei Kinder.
AKTUELLE POSITION
Seit 01/2017
Chefärztin im Zentrum für Dermatochirurgie, Havelklinik Berlin
Seit 01/2009
Wissenschaftliche Mitarbeiterin Charité Universitätsmedizin,
Leitung des klinischen Forschungsbereichs Acne inversa
Principal investigator klinischer Studien im Bereich Acne inversa
BERUFLICHER WERDEGANG
07/2012 – 12/2016
Leitung der Dermatochirurgie in der Klinik für Dermatologie, Venerologie
und Allergologie, Charité Universitätsmedizin.
08/2013
Anerkennung der Zusatzbezeichnung Phlebologie, Ärztekammer Berlin
Promotionsarbeit
10/2000
Promotion im Fach Medizin an der Universität zu
Köln. Note: Magna cum laude.
Studium
05/1999
Abschluss des Studiums der Medizin mit dem
dritten Staatsexamen, Gesamtnote: sehr gut.
1992 – 1999
Studium der Medizin an der Universität zu Köln.
Auslandsaufenthalt
09/2001 - 09/2003
Postdoctoral Research Fellow im Norris
Comprehensive Cancer Center, University of
Southern California, Los Angeles, USA. Principal
Investigator: Professor Dr. Peter V. Danenberg.
und Allergologie, Charité Universitätsmedizin.
Titel des Projektes: Development of tailored
cancer treatment. Investigation of mRNA-expression levels of tumor related genes and their
relationship to clinical response to treatment.
11/2008
Kontakt
01/2009
Ernennung zur Oberärztin in der Klinik für Dermatologie, Venerologie
Anerkennung als Fachärztin für Dermatologie und Venerologie,
Ärztekammer Berlin
T (030) 362 06 - 390
F (030) 362 06 - 100
[email protected]
HAVELKLINIK GMBH & CO. KG
Gatower Straße 191
13595 Berlin-Spandau
10/2003 – 11/2008
Facharztausbildung an der Klinik für Dermatologie, Venerologie
und Allergologie, Charité Universitätsmedizin.
Klinikdirektor: Professor Dr. W. Sterry
07/1999 – 08/2001
Ärztin im Praktikum und im Anschluss Assistenzärztin an der Klinik
und Poliklinik für Visceral- und Gefäßchirurgie der Universität zu Köln.
Klinikdirektor: Professor Dr. A.H. Hölscher.
Arbeitsbereich: Allgemeinchirurgische Intensivstation, Gefäßchirurgie
12/2000
Approbation als Ärztin.
MANUSKRIPTE
Wolk K, Wenzel J, Tsaousi A, Witte-Händel E, Babel N, Zelenak C, Volk HD, Sterry W, Schneider-Burrus S, Sabat
R.Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease
activity in acne inversa / hidradenitis suppurativa. Br J Dermatol. 2017 Mar 3. doi: 10.1111/bjd.15424
Tsaousi A, Witte E, Witte K, Röwert-Huber HJ, Volk HD, Sterry W, Wolk K, Schneider-Burrus S, Sabat R. MMP8
is increased in lesions and blood of acne inversa patients: a potential link to skin destruction and metabolic
alterations. Mediators Inflamm. 2016;2016:4097574. Epub 2016 Oct 23.
Sylke Schneider-Burrus, Ellen Witte, Demetrios Christou, Benedetta Rigoni, Robert Sabat, Gerd Diederichs.
High prevalence of back pain and axial spondyloarthropathy in patients with hidradenitis suppurativa, Dermatology. 2016;232(5):606-612.
Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhász I, Lapins J, Matusiak L, Prens EP, Revuz J,
Schneider-Burrus S, Szepietowski JC, van der Zee HH, Jemec GB. European S1 guideline for the treatment of
hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015 Apr;29(4):619-44
Kurek A, Peters E, Sabat R, Sterry W, Schneider-Burrus S. Depression is a frequent co-morbidity in patients with
acne inversa. J Dtsch Dermatol Ges 2013 Aug;11(8):743-9. (IF 1,403)
Sabat R, Chanwangpong A, Schneider-Burrus S, Metternich D, Kokolakis G, Kurek A, Philipp S, Uribe D, Wolk K,
Sterry W. Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One. 2012;7(2):e31810.
Epub 2012 Feb 16. (IF 4,092)
Kurek A, Chanwangpong A, Sabat R, Peters E, Sterry W, Schneider-Burrus S. Profound disturbances of sexual
health in patients with Acne inversa. J Am Acad Dermatol. 2012 Sep;67(3):422-8 (IF 3,991)
Wolk K, Warszawska K, Hoeflich C, Witte E, Schneider-Burrus S, Witte K, Kunz S, Buss A, Roewert HJ, Krause
M, Lukowsky A, Volk HD, Sterry W, Sabat R. Deficiency of IL-22 contributes to a chronic inflammatory disease:
pathogenetic mechanisms in acne inversa. J Immunol. 2011 Jan 15;186(2):1228-39. (IF 5,788)
Lukowsky A, Sterry W, Schneider-Burrus S. Prevalence of the MspI and Ile462Val SNPs of cytochrome P-450 1A1
in hidradenitis suppurativa. Exp Dermatol. 2010 Jun;19(6):541-2. (IF 4,159)
Schneider-Burrus S, Drecoll U, Schlag PM. Operative Therapie des malignen Melanoms. Der Onkologe, 2009,
Volume 15, Number 8, 750-757. (IF 0,157)
Kuramochi H, Uchida K, Peters JH, Shimizu D, Vallbohmer D, Schneider S, Danenberg KD, Danenberg PV. Loss of
heterozygosity at thymidylate synthase locus in Barrett's metaplasia, dysplasia, and carcinoma sequences. BMC
Cancer. 2009 May 21;9:157. (IF 2,736)
Schneider-Burrus S, Meixner D, Sterry W, Luckowsky A. Common NOD2 mutations are rare in patients with
inverse acne. J Dermatol Sci. 2008 Oct;52(1):55-7. (IF 2,973)
Meixner D, Schneider S, Krause M, Sterry W. Acne inversa. A review. J Dtsch Dermatol Ges. 2008 Mar;6(3):189-96.
Yang D, Schneider S, Azuma M, Iqbal S, El-Khoueiry A, Groshen S, Agafitei D, Danenberg KD, Danenberg PV, Ladner RD, Lenz HJ. Gene expression levels of epidermal growth factor receptor, survivin, and vascular endothelial
growth factor as molecular markers of lymph node involvement in patients with locally advanced rectal cancer.
Clin Colorectal Cancer. 2006 Nov;6(4):305-11.
Maza S, Taupitz M, Taymoorian K, Winzer KJ, Ruckert J, Paschen C, Raber G, Schneider S, Trefzer U, Munz DL.
Multimodal fusion imaging ensemble for targeted sentinel lymph node management: initial results of an innovative promising approach for anatomically difficult lymphatic drainage in different tumour entities. Eur J Nucl
Med Mol Imaging. 2007 Mar;34(3):378-83. (IF 4,101)
Schneider S, Park D, Yang D, El-Khoueiry A, Sherrod A, Groshen S, Streeter O, Iqbal S, Danenberg K, and Lenz
HJ. Gene association in tumor-adjacent normal tissue is associated with recurrence in patients with rectal cancer treated with adjuvant chemoradiation. Pharmacogenet Genomics. 2006 Aug;16(8):555-63. (IF 5,391)
Schneider S, Garcia Bartels C, Maza S, and Sterry W. Detection of Micrometastasis in a Sentinel Lymph Node of
a Patient with Malignant Blue Nevus: A Case Report. Dermatol Surg. 2006 Aug;32(8):1089-92. (IF 2,309)
Dang C, Gottschling M, Manning K, O´Currain E, Schneider S, Sterry W, Stockfleth E and Nindl I. Identification of
dysregulated genes in cutaneous squamous cell carcinoma, Oncol Rep, 2006 Sep;16(3):513-9. (IF 1,567)
Shimizu D, Vallbohmer D, Kuramochi H, Uchida K, Schneider S, Chandrasoma PT, Shimada H, Demeester TR,
Danenberg KD, Peters JH, Demeester SR, Danenberg PV. Increasing cyclooxygenase-2 (cox-2) gene expression
in the progression of Barrett's esophagus to adenocarcinoma correlates with that of Bcl-2. Int J Cancer. 2006
Aug 15;119(4):765-70. (IF 4,693)
Maza S, Trefzer U, Hofmann M, Schneider S, Voit C, Krossin T, Zander A, Audring H, Sterry W, Munz DL. Impact
of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review
of the literature. Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):433-40. (IF 4,041)
Gordon MA, Gil J, Lu B, Zhang W, Yang D, Yun J, Schneider S, Groshen S, Iqbal S, Press OA, Rhodes K, Lenz HJ.
Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation. Pharmacogenomics. 2006 Jan;7(1):67-88. (IF 3,603
Uchida K, Schneider S, Yochim JM, Kuramochi H, Hayashi K, Takasaki K, Yang D, Danenberg KD, Danenberg PV.
Related Articles, Intratumoral COX-2 gene expression is a predictive factor for colorectal cancer response to
fluoropyrimidine-based chemotherapy. Clin Cancer Res. 2005 May 1;11(9):3363-8. (IF 5,715)
Schneider S, Uchida K, Brabender J, Baldus SE, Yochim J, Danenberg KD, Salonga D, Chen P, Tsao-Wei D, Groshen S, Hoelscher AH, Schneider PM, Danenberg PV. Related Articles, Downregulation of TS, DPD, ERCC1, GSTPi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal
cancer. J Am Coll Surg. 2005 Mar;200(3):336-44. (IF 2,621)
Kuramochi H, Vallbohmer D, Uchida K, Schneider S, Hamoui N, Shimizu D, Chandrasoma PT, DeMeester TR, Danenberg KD, Danenberg PV, Peters JH. Related Articles, Quantitative, tissue-specific analysis of cyclooxygenase
gene expression in the pathogenesis of Barrett's adenocarcinoma. J Gastrointest Surg. 2004 Dec;8(8):1007-16.
Hamoui N, Peters JH, Schneider S, Uchida K, Yang D, Vallbohmer D, Hagen JA, DeMeester SR, DeMeester TR,
Danenberg K, Danenberg P. Related Articles, Increased acid exposure in patients with gastroesophageal reflux
disease influences cyclooxygenase-2 gene expression in the squamous epithelium of the lower esophagus. Arch
Surg. 2004 Jul;139(7):712-6. (IF 3,076)
Lu B, Mu Y, Cao C, Zeng F, Schneider S, Tan J, Price J, Chen J, Freeman M, Hallahan DE. Survivin as a therapeutic
target for radiation sensitization in lung cancer. Cancer Res. 2004 Apr 15;64(8):2840-5. (IF 7,69)
Brabender J, Marjoram P, Salonga D, Metzger R, Schneider PM, Park JM, Schneider S, Holscher AH, Yin J,
Meltzer SJ, Danenberg KD, Danenberg PV, Lord RV. Related Articles, A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus. Oncogene. 2004 Jun
10;23(27):4780-8. (IF 6,318)
Schneider S, Yochim J, Brabender J, Uchida K, Danenberg KD, Metzger R, Schneider PM, Salonga D, Holscher
AH, Danenberg PV. Related Articles, Osteopontin but not osteonectin messenger RNA expression is a prognostic
marker in curatively resected non-small cell lung cancer. Clin Cancer Res. 2004 Mar 1;10(5):1588-96. (IF 5,623)
Uchida K, Hayashi K, Kawakami K, Schneider S, Yochim JM, Kuramochi H, Takasaki K, Danenberg KD, Danenberg
PV. Related Articles, Loss of heterozygosity at the thymidylate synthase (TS) locus on chromosome 18 affects
tumor response and survival in individuals heterozygous for a 28-bp polymorphism in the TS gene. Clin Cancer
Res. 2004 Jan 15;10(2):433- (IF 5,623)
Schneider S, Uchida K, Salonga D, Yochim JM, Danenberg KD, Danenberg PV. Quantitative determination of p16
gene expression by RT-PCR. Methods Mol Biol. 2004;281:91-103.
Schneider S, Stöhlmacher J and Lenz H-J, Pharmakogenetik in kolorektalen Karzinomen, Der Onkologe 2003,
Aug, Volume 9, Number 8
Brabender J, Usadel H, Metzger R, Schneider PM, Park J, Salonga D, Tsao-Wei DD, Groshen S, Lord RV, Takebe
N, Schneider S, Holscher AH, Danenberg KD, Danenberg PV. Related Articles, Quantitative O(6)-methylguanine
DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with
clinical outcome. Clin Cancer Res. 2003 Jan;9(1):223-7.